Perceptions of Pap screenings in relation to the HPV vaccine

July 25, 2018, The City University of New York
Electron micrograph of a negatively stained human papilloma virus (HPV) which occurs in human warts. Credit: public domain

Cervical cancer, the second most common cancer affecting women worldwide, is caused by infection with the Human papillomavirus (HPV), which is transmitted sexually. Reflecting the wide reach of the HPV virus, it has been estimated that over 80% of sexually active females will be infected with HPV in their lifetimes. While HPV infection is often harmless, clearing up on its own, persistent infection can lead to development of cervical cancer.

A development in the prevention of in women in Australia was the introduction of the HPV , which was made available to young women as part of a national school-based vaccination program in 2007. Despite this medical advancement, regular Pap screening is still required to provide optimal protection from cervical .

At the time of this study, participation in Pap screenings among Australian women had been declining steadily since 1996. The introduction of the National HPV Vaccination Program in Australia in 2007 raised concerns that the declining rates of Pap screening participation among young women would be exacerbated by the availability and promotion of the vaccine. However, a survey conducted in 2009 showed that 96% of vaccinated women aged 18-28 years knew that Pap screening was still suggested after vaccination. More recent data suggests that knowledge of the need for screening did not translate into corresponding screening-seeking behavior.

Dr. Spring Cooper, a professor at the CUNY Graduate School of Public Health & Health Policy, led a recent study that explored the extent of knowledge among young women in Australia on HPV, HPV vaccinations, and Pap screening guidelines. The study aimed to identify the knowledge, attitudes, and behaviors influencing young women's participation in Pap screenings. The findings were published in the International Journal of Women's Health and Reproductive Sciences.

Cooper and her team conducted semi-structured interviews with 12 women who had been in school and offered the HPV vaccination through the Australian National HPV Vaccination Program. The transcripts of the interviews were analyzed and recurring barriers and facilitators to seeking Pap screenings were identified. Psychological barriers, the most frequently cited barrier amongst the participants, refer to self-limiting beliefs such as a mental reluctance to seek the Pap screening, or a reluctance to disrobe in front of a doctor for the examination. The other barriers included concern about the physical discomfort involved, lack of time, lack of information about where to access a Pap screening, and concerns about the potential costs involved. On the other hand, several facilitators were identified that encouraged the participants to seek screenings. These included focusing on the long-term benefit of screening, maternal support, discussions with friends, having an established relationship with a regular doctor with whom they felt comfortable discussing the issue, and previous Pap screening experience.

The study found that all of the participants understood that Pap screening was necessary regardless of vaccination status. Despite this knowledge, the adherence to the guidelines for screening varied due to a range of barriers and facilitators. The participants themselves made several recommendations in the course of the interviews for encouraging young women to adhere to the Pap screening guidelines. The recommendations included increasing knowledge, improving education, reducing stigma, and improving accessibility to screenings.

With cervical cancer being one of the most common forms of cancer affecting , an increased understanding of and adherence to the recommended preventive measures to reduce risk is crucial to decreasing rates of morbidity and mortality from cervical cancer. The authors point out that the findings from this study have implications for the development of interventions to ensure adherence to Pap guidelines is maintained in both vaccinated and unvaccinated in Australia.

Explore further: HPV vaccine reduced cervical abnormalities in young women

More information: Perceptions of Pap screening in a context of HPV vaccination. International Journal of Women's Health and Reproductive Sciences. DOI: 10.15296/ijwhr.2018. 41

Related Stories

HPV vaccine reduced cervical abnormalities in young women

July 4, 2016
Young women who received the human papillomavirus (HPV) vaccine through a school-based program had fewer cervical cell anomalies when screened for cervical cancer, found a new study in CMAJ (Canadian Medical Association Journal).

How have HPV vaccines affected cervical cancer screening?

June 7, 2017
A new review looks at cervical cancer screening in the era of HPV vaccination. The review notes that trials have demonstrated the efficacy and safety of vaccines against HPV infection, but the complete effect of HPV vaccination ...

HPV jab means women only need 3 cervical screens in a lifetime

November 10, 2017
Women may only need three cervical screens in their lifetime if they have been given the human papillomavirus (HPV) vaccine, according to a new study published in the International Journal of Cancer today (Friday).

Study finds decreased rates of high-grade cervical lesions in young women

June 22, 2015
A new analysis indicates that rates of high-grade cervical lesions decreased in young U.S. women after vaccines were made available to protect against human papillomavirus (HPV), but the trend may be due in part to changes ...

Cervical cancer screening could be less frequent, start later

October 17, 2016
Women may only need cervical cancer screening every 5-10 years—instead of every three years, as currently recommended—and may be able to start the screenings later in life, according to a new study from Harvard T.H. Chan ...

Schoolgirl cancer vaccination encourages mothers to attend cervical screening

November 12, 2015
Manchester researchers have shown that the introduction of the HPV vaccination programme for girls has increased uptake for cervical cancer screening by their mothers.

Recommended for you

Week 34 of pregnancy reduces breast cancer risk: study

October 23, 2018
Women's bodies undergo a "striking" change during a specific week of pregnancy that can significantly reduce their risk of developing breast cancer later in life, scientists said Tuesday.

New kind of compound shows early promise against prostate cancer

October 23, 2018
A new type of molecule blocks the action of genes that drive the growth of therapy-resistant prostate cancer, a new study finds.

New combination treatment flips the switch on melanoma cells

October 23, 2018
Think of the protein BH3 like a finger that turns off a cancer cell survival switch. The problem is that most cancer cells have found ways to remove this "finger—commonly, by breaking the action of a gene called p53 that ...

Desperate & duped? GoFundMe means big bucks for dubious care

October 23, 2018
People seeking dubious, potentially harmful treatment for cancer and other ailments raised nearly $7 million over two years from crowdfunding sites, a study found.

Marker found for condition that causes numerous tumors

October 23, 2018
UT Southwestern researchers have made a major advance in uncovering the biology of how thousands of disfiguring skin tumors occur in patients troubled by a genetic disorder called neurofibromatosis type 1 (NF1). This scientific ...

Urban and rural rates of childhood cancer survival the same, study finds

October 23, 2018
Childhood and adolescent cancer survival in the United States does not vary by rural/urban residence at the time of diagnosis, finds a new study from the Brown School at Washington University in St. Louis.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.